Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001335922 | SCV001529182 | likely pathogenic | Charcot-Marie-Tooth disease axonal type 2Q | 2018-04-10 | criteria provided, single submitter | clinical testing | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001865840 | SCV002151967 | pathogenic | 2-aminoadipic 2-oxoadipic aciduria | 2023-11-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg455*) in the DHTKD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DHTKD1 are known to be pathogenic (PMID: 23141293, 25860818). This variant is present in population databases (rs201369986, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with DHTKD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1033496). For these reasons, this variant has been classified as Pathogenic. |
Prevention |
RCV004749660 | SCV005360139 | likely pathogenic | DHTKD1-related disorder | 2024-09-26 | no assertion criteria provided | clinical testing | The DHTKD1 c.1363C>T variant is predicted to result in premature protein termination (p.Arg455*). To our knowledge this variant has not been reported in the literature. This variant is reported in 0.0048% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in DHTKD1 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |